{"ticker": "GEMP", "overview": {"cik": "1638287", "ticker": "MTVA", "name": "MetaVia Inc.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "8-K", "date": "2026-10-28", "title": "Material event", "accession": "0001104659-26-119401", "price_sensitive": true}, {"form": "4", "date": "2026-10-13", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-115494", "price_sensitive": false}, {"form": "3", "date": "2026-10-13", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-115491", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-13", "title": "Material event", "accession": "0001104659-26-115300", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-09", "title": "Material event", "accession": "0001104659-26-106156", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "Quarterly report", "accession": "0001104659-26-092051", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "Material event", "accession": "0001104659-26-091981", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-09", "title": "FORM 8-K", "accession": "0001104659-26-082116", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-02", "title": "FORM 8-K", "accession": "0001104659-26-080316", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-02", "title": "Prospectus", "accession": "0001104659-26-080305", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071475", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071474", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071473", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071472", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071471", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071469", "price_sensitive": false}, {"form": "S-8", "date": "2026-06-08", "title": "FORM S-8", "accession": "0001104659-26-071406", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-08", "title": "FORM 8-K", "accession": "0001104659-26-071358", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-08", "title": "Material event", "accession": "0001104659-26-071211", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-27", "title": "Material event", "accession": "0001104659-26-066631", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-18", "title": "Material event", "accession": "0001104659-26-063059", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-05-15", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-002373", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-14", "title": "Quarterly report", "accession": "0001104659-26-061166", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-14", "title": "Material event", "accession": "0001104659-26-061148", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-11", "title": "Material event", "accession": "0001104659-26-058332", "price_sensitive": true}]}, "description": "GEMP trades as GEMP. Privy Trades holds 55 insider filings for the company, from August 2016 to February 2018. Across those, 10 insiders disclosed 15 open-market purchases totalling $8.23M. The most recent filing on record is dated 24 July 2019.", "exchange": null, "stats": {"buy_n": 15, "buy_sum": 8230442.72, "sell_n": 0, "sell_sum": 0, "net": 8230442.72, "insiders": 10, "first_date": "2016-08-10", "last_date": "2018-02-08"}, "metrics": {"ticker": "GEMP", "has_prices": false}, "trades": [{"id": "0001596771-19-000080", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677119000080/0001596771-19-000080-index.htm", "trade_date": "2019-07-24", "timestamp": "2019-07-24", "mins": 3828470}, {"id": "0001596771-19-000081", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Charles Bisgaier PhD", "who_key": "Bisgaier Charles PhD", "role": "Chief Scientific Off. & Chair, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677119000081/0001596771-19-000081-index.htm", "trade_date": "2019-07-24", "timestamp": "2019-07-24", "mins": 3828470}, {"id": "0001596771-19-000082", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Seth Reno", "who_key": "Reno Seth", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677119000082/0001596771-19-000082-index.htm", "trade_date": "2019-07-24", "timestamp": "2019-07-24", "mins": 3828470}, {"id": "0001596771-19-000083", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Kenneth W. Kousky", "who_key": "KOUSKY KENNETH W", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677119000083/0001596771-19-000083-index.htm", "trade_date": "2019-07-24", "timestamp": "2019-07-24", "mins": 3828470}, {"id": "0001596771-19-000084", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Pedro Lichtinger", "who_key": "LICHTINGER PEDRO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677119000084/0001596771-19-000084-index.htm", "trade_date": "2019-07-24", "timestamp": "2019-07-24", "mins": 3828470}, {"id": "0001596771-19-000085", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Andy Sassine", "who_key": "SASSINE ANDY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677119000085/0001596771-19-000085-index.htm", "trade_date": "2019-07-24", "timestamp": "2019-07-24", "mins": 3828470}, {"id": "0001596771-18-000061", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000061/0001596771-18-000061-index.htm", "trade_date": "2018-05-22", "timestamp": "2018-05-22", "mins": 4444790}, {"id": "0001596771-18-000053", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000053/0001596771-18-000053-index.htm", "trade_date": "2018-05-01", "timestamp": "2018-05-01", "mins": 4475030}, {"id": "0001596771-18-000019", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Interim President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 500003.0, "score": 58.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "GEMP catches the CEO's eye: $500K bought", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000019/0001596771-18-000019-index.htm", "trade_date": "2018-02-08", "timestamp": "2018-02-08", "mins": 4593110}, {"id": "0001596771-18-000020", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Seth Reno", "who_key": "Reno Seth", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 100002.0, "score": 57.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Executive suite buys $100K of GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000020/0001596771-18-000020-index.htm", "trade_date": "2018-02-08", "timestamp": "2018-02-08", "mins": 4593110}, {"id": "0001596771-18-000009", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Interim President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000009/0001596771-18-000009-index.htm", "trade_date": "2018-01-29", "timestamp": "2018-01-29", "mins": 4607510}, {"id": "0001596771-18-000014", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "P. Kent Hawryluk", "who_key": "Hawryluk P. Kent", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000014/0001596771-18-000014-index.htm", "trade_date": "2018-01-29", "timestamp": "2018-01-29", "mins": 4607510}, {"id": "0001596771-18-000015", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Kenneth W. Kousky", "who_key": "KOUSKY KENNETH W", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000015/0001596771-18-000015-index.htm", "trade_date": "2018-01-29", "timestamp": "2018-01-29", "mins": 4607510}, {"id": "0001596771-18-000016", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Pedro Lichtinger", "who_key": "LICHTINGER PEDRO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000016/0001596771-18-000016-index.htm", "trade_date": "2018-01-29", "timestamp": "2018-01-29", "mins": 4607510}, {"id": "0001596771-18-000017", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Andy Sassine", "who_key": "SASSINE ANDY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000017/0001596771-18-000017-index.htm", "trade_date": "2018-01-29", "timestamp": "2018-01-29", "mins": 4607510}, {"id": "0001596771-18-000010", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Seth Reno", "who_key": "Reno Seth", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000010/0001596771-18-000010-index.htm", "trade_date": "2018-01-28", "timestamp": "2018-01-28", "mins": 4608950}, {"id": "0001596771-18-000011", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Jeffrey S. Mathiesen", "who_key": "MATHIESEN JEFFREY S", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000011/0001596771-18-000011-index.htm", "trade_date": "2018-01-28", "timestamp": "2018-01-28", "mins": 4608950}, {"id": "0001596771-18-000012", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Lee Scott Golden", "who_key": "Golden Lee Scott", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000012/0001596771-18-000012-index.htm", "trade_date": "2018-01-28", "timestamp": "2018-01-28", "mins": 4608950}, {"id": "0001596771-18-000013", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Charles Bisgaier PhD", "who_key": "Bisgaier Charles PhD", "role": "Chief Scien Officer & Chair, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000013/0001596771-18-000013-index.htm", "trade_date": "2018-01-28", "timestamp": "2018-01-28", "mins": 4608950}, {"id": "0001596771-17-000067", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Jeffrey S. Mathiesen", "who_key": "MATHIESEN JEFFREY S", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 11513.13, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000067/0001596771-17-000067-index.htm", "trade_date": "2017-08-14", "timestamp": "2017-08-14", "mins": 4849430}, {"id": "0001104659-17-051365", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Jeffrey S. Mathiesen", "who_key": "MATHIESEN JEFFREY S", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 10770.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465917051365/0001104659-17-051365-index.htm", "trade_date": "2017-08-10", "timestamp": "2017-08-10", "mins": 4855190}, {"id": "0001596771-17-000066", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Jeffrey S. Mathiesen", "who_key": "MATHIESEN JEFFREY S", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 10770.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000066/0001596771-17-000066-index.htm", "trade_date": "2017-08-10", "timestamp": "2017-08-10", "mins": 4855190}, {"id": "0001596771-17-000065", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Charles Bisgaier PhD", "who_key": "Bisgaier Charles PhD", "role": "Chief Scientific Off. & Chair, Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 6013.0560000000005, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000065/0001596771-17-000065-index.htm", "trade_date": "2017-07-31", "timestamp": "2017-07-31", "mins": 4869590}, {"id": "0001596771-17-000041", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Interim President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000041/0001596771-17-000041-index.htm", "trade_date": "2017-05-30", "timestamp": "2017-05-30", "mins": 4958870}, {"id": "0001596771-17-000024", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Lee Scott Golden", "who_key": "Golden Lee Scott", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000024/0001596771-17-000024-index.htm", "trade_date": "2017-03-28", "timestamp": "2017-03-28", "mins": 5049590}, {"id": "0001596771-17-000020", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 499997.06000000006, "score": 48.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 6 buying GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000020/0001596771-17-000020-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000021", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "P. Kent Hawryluk", "who_key": "Hawryluk P. Kent", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 236750.00000000003, "score": 50.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 5 buying GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000021/0001596771-17-000021-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000022", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Pedro Lichtinger", "who_key": "LICHTINGER PEDRO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 99993.73000000001, "score": 42.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying GEMP \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000022/0001596771-17-000022-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000023", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Andy Sassine", "who_key": "SASSINE ANDY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 199996.93000000002, "score": 45.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 3 insiders into GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000023/0001596771-17-000023-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000007", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Kenneth W. Kousky", "who_key": "KOUSKY KENNETH W", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on GEMP \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000007/0001596771-17-000007-index.htm", "trade_date": "2017-02-01", "timestamp": "2017-02-01", "mins": 5128790}], "recent_buys": [{"id": "0001596771-18-000020", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Seth Reno", "who_key": "Reno Seth", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 100002.0, "score": 57.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Executive suite buys $100K of GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000020/0001596771-18-000020-index.htm", "trade_date": "2018-02-08", "timestamp": "2018-02-08", "mins": 4593110}, {"id": "0001596771-18-000019", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Interim President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 500003.0, "score": 58.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "GEMP catches the CEO's eye: $500K bought", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000019/0001596771-18-000019-index.htm", "trade_date": "2018-02-08", "timestamp": "2018-02-08", "mins": 4593110}, {"id": "0001596771-17-000023", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Andy Sassine", "who_key": "SASSINE ANDY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 199996.93000000002, "score": 45.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 3 insiders into GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000023/0001596771-17-000023-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000022", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Pedro Lichtinger", "who_key": "LICHTINGER PEDRO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 99993.73000000001, "score": 42.3, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying GEMP \u2014 4 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000022/0001596771-17-000022-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000021", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "P. Kent Hawryluk", "who_key": "Hawryluk P. Kent", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 236750.00000000003, "score": 50.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 5 buying GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000021/0001596771-17-000021-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001596771-17-000020", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 499997.06000000006, "score": 48.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 6 buying GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000020/0001596771-17-000020-index.htm", "trade_date": "2017-03-10", "timestamp": "2017-03-10", "mins": 5075510}, {"id": "0001104659-16-139283", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "P. Kent Hawryluk", "who_key": "Hawryluk P. Kent", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 250000.0, "score": 55.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying GEMP \u2014 6 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139283/0001104659-16-139283-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380790}, {"id": "0001104659-16-139279", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Pedro Lichtinger", "who_key": "LICHTINGER PEDRO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 100000.0, "score": 42.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "6 insiders pile into GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139279/0001104659-16-139279-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380790}, {"id": "0001104659-16-139276", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Kenneth W. Kousky", "who_key": "KOUSKY KENNETH W", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 10000.0, "score": 27.5, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Insider cluster: 6 buying GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139276/0001104659-16-139276-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380790}, {"id": "0001104659-16-139272", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 5000000.0, "score": 74.4, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 7 insiders into GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139272/0001104659-16-139272-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380790}, {"id": "0001104659-16-139270", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Seth Reno", "who_key": "Reno Seth", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 40000.0, "score": 38.1, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "7 insiders now buying GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139270/0001104659-16-139270-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380790}, {"id": "0001104659-16-139269", "src": "INSIDERS", "ticker": "GEMP", "cik": "1638287", "company": "MetaVia Inc.", "company_raw": "Gemphire Therapeutics Inc.", "who": "Mina Sooch", "who_key": "Sooch Mina", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 525000.0, "score": 58.9, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "7 insiders pile into GEMP", "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139269/0001104659-16-139269-index.htm", "trade_date": "2016-08-10", "timestamp": "2016-08-10", "mins": 5380790}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Steven R. Gullans Ph.D.", "who_key": "Gullans Steven R. Ph.D.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 6000000.0600000005, "sold": 0, "net": 6000000.0600000005, "trades": 3, "top_score": 74.4, "lean": "buying", "history": [{"action": "BUY", "amount": 500003.0, "date": "2018-02-08", "score": 58.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000019/0001596771-18-000019-index.htm"}, {"action": "BUY", "amount": 499997.06000000006, "date": "2017-03-10", "score": 48.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000020/0001596771-17-000020-index.htm"}, {"action": "BUY", "amount": 5000000.0, "date": "2016-08-10", "score": 74.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139272/0001104659-16-139272-index.htm"}], "latest": {"action": "BUY", "amount": 500003.0, "date": "2018-02-08", "score": 58.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000019/0001596771-18-000019-index.htm"}}, {"who": "Mina Sooch", "who_key": "Sooch Mina", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 525000.0, "sold": 0, "net": 525000.0, "trades": 1, "top_score": 58.9, "lean": "buying", "history": [{"action": "BUY", "amount": 525000.0, "date": "2016-08-10", "score": 58.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139269/0001104659-16-139269-index.htm"}], "latest": {"action": "BUY", "amount": 525000.0, "date": "2016-08-10", "score": 58.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139269/0001104659-16-139269-index.htm"}}, {"who": "Charles Bisgaier PhD", "who_key": "Bisgaier Charles PhD", "role": "Chair & Chief Scientific Off., Director, 10% Owner", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 517500.0, "sold": 0, "net": 517500.0, "trades": 1, "top_score": 52.0, "lean": "buying", "history": [{"action": "BUY", "amount": 517500.0, "date": "2016-08-10", "score": 52.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139254/0001104659-16-139254-index.htm"}], "latest": {"action": "BUY", "amount": 517500.0, "date": "2016-08-10", "score": 52.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139254/0001104659-16-139254-index.htm"}}, {"who": "P. Kent Hawryluk", "who_key": "Hawryluk P. Kent", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 486750.0, "sold": 0, "net": 486750.0, "trades": 2, "top_score": 55.6, "lean": "buying", "history": [{"action": "BUY", "amount": 236750.00000000003, "date": "2017-03-10", "score": 50.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000021/0001596771-17-000021-index.htm"}, {"action": "BUY", "amount": 250000.0, "date": "2016-08-10", "score": 55.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139283/0001104659-16-139283-index.htm"}], "latest": {"action": "BUY", "amount": 236750.00000000003, "date": "2017-03-10", "score": 50.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000021/0001596771-17-000021-index.htm"}}, {"who": "Andy Sassine", "who_key": "SASSINE ANDY", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 199996.93000000002, "sold": 0, "net": 199996.93000000002, "trades": 1, "top_score": 45.4, "lean": "buying", "history": [{"action": "BUY", "amount": 199996.93000000002, "date": "2017-03-10", "score": 45.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000023/0001596771-17-000023-index.htm"}], "latest": {"action": "BUY", "amount": 199996.93000000002, "date": "2017-03-10", "score": 45.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000023/0001596771-17-000023-index.htm"}}, {"who": "Pedro Lichtinger", "who_key": "LICHTINGER PEDRO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 199993.73, "sold": 0, "net": 199993.73, "trades": 2, "top_score": 42.9, "lean": "buying", "history": [{"action": "BUY", "amount": 99993.73000000001, "date": "2017-03-10", "score": 42.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000022/0001596771-17-000022-index.htm"}, {"action": "BUY", "amount": 100000.0, "date": "2016-08-10", "score": 42.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139279/0001104659-16-139279-index.htm"}], "latest": {"action": "BUY", "amount": 99993.73000000001, "date": "2017-03-10", "score": 42.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677117000022/0001596771-17-000022-index.htm"}}, {"who": "Seth Reno", "who_key": "Reno Seth", "role": "Chief Commercial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 140002.0, "sold": 0, "net": 140002.0, "trades": 2, "top_score": 57.8, "lean": "buying", "history": [{"action": "BUY", "amount": 100002.0, "date": "2018-02-08", "score": 57.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000020/0001596771-18-000020-index.htm"}, {"action": "BUY", "amount": 40000.0, "date": "2016-08-10", "score": 38.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139270/0001104659-16-139270-index.htm"}], "latest": {"action": "BUY", "amount": 100002.0, "date": "2018-02-08", "score": 57.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000159677118000020/0001596771-18-000020-index.htm"}}, {"who": "David Lowenschuss", "who_key": "Lowenschuss David", "role": "Chief Legal Off. & Secretary", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 111200.0, "sold": 0, "net": 111200.0, "trades": 1, "top_score": 43.6, "lean": "buying", "history": [{"action": "BUY", "amount": 111200.0, "date": "2016-08-10", "score": 43.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139262/0001104659-16-139262-index.htm"}], "latest": {"action": "BUY", "amount": 111200.0, "date": "2016-08-10", "score": 43.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1638287/000110465916139262/0001104659-16-139262-index.htm"}}], "activity": [], "announcements": [{"form": "8-K", "date": "2026-10-28", "title": "Material event", "accession": "0001104659-26-119401", "price_sensitive": true}, {"form": "4", "date": "2026-10-13", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-115494", "price_sensitive": false}, {"form": "3", "date": "2026-10-13", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-115491", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-13", "title": "Material event", "accession": "0001104659-26-115300", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-09", "title": "Material event", "accession": "0001104659-26-106156", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "Quarterly report", "accession": "0001104659-26-092051", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "Material event", "accession": "0001104659-26-091981", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-09", "title": "FORM 8-K", "accession": "0001104659-26-082116", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-02", "title": "FORM 8-K", "accession": "0001104659-26-080316", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-02", "title": "Prospectus", "accession": "0001104659-26-080305", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071475", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071474", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071473", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071472", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071471", "price_sensitive": false}, {"form": "4", "date": "2026-06-08", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-071469", "price_sensitive": false}, {"form": "S-8", "date": "2026-06-08", "title": "FORM S-8", "accession": "0001104659-26-071406", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-08", "title": "FORM 8-K", "accession": "0001104659-26-071358", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-08", "title": "Material event", "accession": "0001104659-26-071211", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-27", "title": "Material event", "accession": "0001104659-26-066631", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-18", "title": "Material event", "accession": "0001104659-26-063059", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-05-15", "title": "Form SCHEDULE 13G", "accession": "0001172661-26-002373", "price_sensitive": false}, {"form": "10-Q", "date": "2026-05-14", "title": "Quarterly report", "accession": "0001104659-26-061166", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-14", "title": "Material event", "accession": "0001104659-26-061148", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-11", "title": "Material event", "accession": "0001104659-26-058332", "price_sensitive": true}], "performance": {"ticker": "GEMP", "has_prices": false, "summary": null, "buys": [{"who": "Reno Seth", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Commercial Officer", "amount": 100002.0, "date": "2018-02-08", "score": 57.8, "ref_price": null, "return": null}, {"who": "Gullans Steven R. Ph.D.", "person_type": "CEO", "person_label": "CEOs", "role": "Interim President & CEO, Director", "amount": 500003.0, "date": "2018-02-08", "score": 58.6, "ref_price": null, "return": null}, {"who": "SASSINE ANDY", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 199996.93000000002, "date": "2017-03-10", "score": 45.4, "ref_price": null, "return": null}, {"who": "LICHTINGER PEDRO", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 99993.73000000001, "date": "2017-03-10", "score": 42.3, "ref_price": null, "return": null}, {"who": "Hawryluk P. Kent", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 236750.00000000003, "date": "2017-03-10", "score": 50.1, "ref_price": null, "return": null}, {"who": "Gullans Steven R. Ph.D.", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 499997.06000000006, "date": "2017-03-10", "score": 48.4, "ref_price": null, "return": null}, {"who": "Hawryluk P. Kent", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 250000.0, "date": "2016-08-10", "score": 55.6, "ref_price": null, "return": null}, {"who": "LICHTINGER PEDRO", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 100000.0, "date": "2016-08-10", "score": 42.9, "ref_price": null, "return": null}, {"who": "KOUSKY KENNETH W", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 10000.0, "date": "2016-08-10", "score": 27.5, "ref_price": null, "return": null}, {"who": "Gullans Steven R. Ph.D.", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 5000000.0, "date": "2016-08-10", "score": 74.4, "ref_price": null, "return": null}, {"who": "Reno Seth", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Commercial Officer", "amount": 40000.0, "date": "2016-08-10", "score": 38.1, "ref_price": null, "return": null}, {"who": "Sooch Mina", "person_type": "CEO", "person_label": "CEOs", "role": "President & CEO, Director", "amount": 525000.0, "date": "2016-08-10", "score": 58.9, "ref_price": null, "return": null}, {"who": "Lowenschuss David", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Legal Off. & Secretary", "amount": 111200.0, "date": "2016-08-10", "score": 43.6, "ref_price": null, "return": null}, {"who": "MATHIESEN JEFFREY S", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 40000.0, "date": "2016-08-10", "score": 56.9, "ref_price": null, "return": null}, {"who": "Bisgaier Charles PhD", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chair & Chief Scientific Off., Director, 10% Owner", "amount": 517500.0, "date": "2016-08-10", "score": 52.0, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}